0001209191-20-044378.txt : 20200731
0001209191-20-044378.hdr.sgml : 20200731
20200731210559
ACCESSION NUMBER: 0001209191-20-044378
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190909
FILED AS OF DATE: 20200731
DATE AS OF CHANGE: 20200731
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BILINSKY IGOR
CENTRAL INDEX KEY: 0001594604
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50549
FILM NUMBER: 201067615
MAIL ADDRESS:
STREET 1: C/O VICAL INCORPORATED
STREET 2: 10390 PACIFIC CENTER COURT
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Oncternal Therapeutics, Inc.
CENTRAL INDEX KEY: 0001260990
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 621715807
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12230 EL CAMINO REAL
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858) 434-1113
MAIL ADDRESS:
STREET 1: 12230 EL CAMINO REAL
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: GTX INC /DE/
DATE OF NAME CHANGE: 20030822
4/A
1
doc4a.xml
FORM 4/A SUBMISSION
X0306
4/A
2019-09-09
2019-09-09
0
0001260990
Oncternal Therapeutics, Inc.
ONCT
0001594604
BILINSKY IGOR
12230 EL CAMINO REAL, SUITE 300
SAN DIEGO
CA
92130
0
1
0
0
Chief Business Officer
Stock Option
5.33
2019-09-09
4
A
0
150000
0.00
A
2029-09-09
Common Stock
150000
150000
D
The original Form 4 reported the acquisition of the Stock Options in the "D" column of Column 5. This amendment is being filed to correctly report the acquisition of the Stock Options in the "A" column of Column 5.
One-fourth (1/4th) of the shares subject to the stock options shall vest on first anniversary of the date of grant, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments over the three-year period thereafter, subject to the Reporting Persons continued employment or service with the Issuer on each such date.
/s/ Hazel M. Aker, Attorney-in-fact
2020-07-31